Use of genomic signatures in therapeutics development in oncology and other diseases.
- Published in:
- Pharmacogenomics Journal, 2006, v. 6, n. 3, p. 166, doi. 10.1038/sj.tpj.6500349
- By:
- Publication type:
- Article
Works matching IS 1470269X AND DT 2006 AND VI 6 AND IP 3
Results: 11
1
2
Influence of phenotype and pharmacokinetics on β-blocker drug target pharmacogenetics.
- Published in:
- Pharmacogenomics Journal, 2006, v. 6, n. 3, p. 174, doi. 10.1038/sj.tpj.6500354
- By:
- Publication type:
- Article
3
Linkage disequilibrium and association with methamphetamine dependence/psychosis of μ-opioid receptor gene polymorphisms.
- Published in:
- Pharmacogenomics Journal, 2006, v. 6, n. 3, p. 179, doi. 10.1038/sj.tpj.6500355
- By:
- Publication type:
- Article
4
Interaction between variation in the D2 dopamine receptor (DRD2) and the neuronal calcium sensor-1 (FREQ) genes in predicting response to nicotine replacement therapy for tobacco dependence.
- Published in:
- Pharmacogenomics Journal, 2006, v. 6, n. 3, p. 194, doi. 10.1038/sj.tpj.6500358
- By:
- Publication type:
- Article
5
The role of Gilbert's syndrome and frequent NAT2 slow acetylation polymorphisms in the pharmacokinetics of retigabine.
- Published in:
- Pharmacogenomics Journal, 2006, v. 6, n. 3, p. 211, doi. 10.1038/sj.tpj.6500359
- By:
- Publication type:
- Article
6
Pharmacogenetics and pharmacogenomics: origin, status, and the hope for personalized medicine.
- Published in:
- Pharmacogenomics Journal, 2006, v. 6, n. 3, p. 162, doi. 10.1038/sj.tpj.6500361
- By:
- Publication type:
- Article
7
Relevance of frequent μ-opioid receptor polymorphisms for opioid activity in healthy volunteers.
- Published in:
- Pharmacogenomics Journal, 2006, v. 6, n. 3, p. 200, doi. 10.1038/sj.tpj.6500362
- By:
- Publication type:
- Article
8
Pharmacogenomics and regulatory decision making: an international perspective.
- Published in:
- Pharmacogenomics Journal, 2006, v. 6, n. 3, p. 154, doi. 10.1038/sj.tpj.6500364
- By:
- Publication type:
- Article
9
Estrogen-metabolizing gene polymorphisms in the assessment of female hormone-dependent cancer risk.
- Published in:
- Pharmacogenomics Journal, 2006, v. 6, n. 3, p. 189, doi. 10.1038/sj.tpj.6500365
- By:
- Publication type:
- Article
10
Pharmacovigilance in a genomic era.
- Published in:
- Pharmacogenomics Journal, 2006, v. 6, n. 3, p. 158, doi. 10.1038/sj.tpj.6500370
- By:
- Publication type:
- Article
11
In This Issue.
- Published in:
- Pharmacogenomics Journal, 2006, v. 6, n. 3, p. 153, doi. 10.1038/sj.tpj.6500399
- Publication type:
- Article